1.Statistical Analysis of 631 Cases of Surgically Treated Brain Tumors in Korea University Hospital.
Geun Hoe KIM ; Young Gu CHUNG ; Jung Yui PARK ; Ki Chn LEE ; Hoon Kab LEE
Journal of Korean Neurosurgical Society 1996;25(5):952-961
The authors present a statistical survey of the general incidence, age distribution, and preferential site of 631 tumors of the brain which have been surgically treated at Korea university medical center, department of neurosurgery over the last period of 10 years from 1985 to 1994. Among them 269 cases were males and 362 were females. Of the 631 intracranial neoplasms verified histologically, tumors of neuroepithelial tissue comprised 34%(212 cases), tumors of meninges 23%(148 cases), pituitary adenoma 18%(114 cases), metastatic tumors 8%(50 cases), neurilemmomas 8%(49 cases), germ cell tumors 3%(13 cases), cyst and tumor like lesions 3%(16 cases), and lymphomas 1%(5 cases). Of the 178 gliomas, astrocytic tumors comprised 83%(148 cases), oligodendroglial tumors 11%(20 cases), ependymal tumors 3%(6 cases) and mixed gliomas 1.7%(3 cases). Brain tumors occurred most frequently in the age group of 45-50 years, as seen by an incidence of 63 cases(10%). The male to female ratio was 0.74: 1. Tumors that showed a definitive preponderance of females over males were meningiomas, neurilemmomas, and pituitary adenomas. Supratentoral and infratenorial cases were 73%(461 cases) and 26%(162 cases), respectively and the remaining cases involved both sites. Of the 114 cases of childhood and adolescent tumors, 60 were male and 54 were female. Supratentorial tumors were 56% and infratentorial were 44%. The tumors in order of frequency were astrocytomas(28%), primitive neuroectodermal tumors(21%), craniopharyngioma(10%) and so on. Meningiomas occurred most frequently in parasagittal/falx area(25%), followed by cerebral convexity 23%, sphenoid 14%, posterior fossa 13%. Among pituitary adenomas, prolactinomas(32%) were the most common and followed by null cell adenomas 31%, growth hormone cell adenomas 15%, mixed GH-PRL cell adenomas 11%.
Academic Medical Centers
;
Adenoma
;
Adolescent
;
Age Distribution
;
Astrocytoma
;
Brain Neoplasms*
;
Brain*
;
Female
;
Glioma
;
Growth Hormone
;
Humans
;
Incidence
;
Korea*
;
Lymphocytes, Null
;
Lymphoma
;
Male
;
Meninges
;
Meningioma
;
Neoplasms, Germ Cell and Embryonal
;
Neural Plate
;
Neurilemmoma
;
Neurosurgery
;
Pituitary Neoplasms
;
Supratentorial Neoplasms